$2.12
+0.06 (+2.91%)
Open$2.09
Previous Close$2.06
Day High$2.12
Day Low$2.06
52W High$7.33
52W Low$2.05
Volume—
Avg Volume117.2K
Market Cap37.43M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,667.9% upside
Current
$2.12
$2.12
Target
$37.48
$37.48
$21.76
$37.48 avg
$51.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.30M | 32.73M | 6.59M |
| Net Income | -47,688,577 | -65,949,169 | 1.64M |
| Profit Margin | -223.9% | -212.7% | 24.9% |
| EBITDA | -46,232,074 | -67,486,893 | 3.19M |
| Free Cash Flow | — | — | 1.30M |
| Rev Growth | -34.9% | -34.9% | +19.2% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |